TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/30/2025
Back to search
Official data from USPTO
HENSIFY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
10/08/2025
Trademark type
Combined
Nice classes
5, 10
Filing date
08/03/2017
Registration date
04/03/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2024
Last transaction
10/08/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
PARIS, FR
Examiner
EINSTEIN,MATTHEW T
Current location
Historical data usage
Mark description
The mark consists of the wording "HENSIFY" with a design of nine triangles forming a polygon to the upper right of the wording.
Holders and representatives
Holders
Nanobiotix
Nanobiotix
Representatives
Paul Cosmovici
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsagents for tumor treatment for use only in relation to radiotherapy; medicines for human use for use only in relation to radiotherapy for cancer treatment; healthcare productspharmaceutical products for cancer treatment for use only in relation to radiotherapy; drugs for medical use for cancer treatment for use only in relation to radiotherapy; preparations for medical use for use only in relation to radiotherapyparticularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use for use only in relation to radiotherapy for cancer treatment; medical preparations for medical or pharmaceutical use consisting of medication delivery agents in the form of tablets and capsules for cancer treatment for use only in relation to radiotherapy; chemical-pharmaceutical products consisting in tablets or injectable products for cancer treatment for use only in relation to radiotherapy; diagnostic biomarking reagents for medical use for use only in relation to radiotherapy
Class 10
Diagnostic apparatus for medical useX-ray apparatus for medical use; radiology screens for medical use
Publications
History of USPTO decisions and trademark events.
30 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/30/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/30/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/19/2024
71AG
REGISTERED-SEC.71 ACCEPTED
11/19/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/18/2024
ES71
TEAS SECTION 71 RECEIVED
04/03/2024
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
08/04/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/10/2018
FIMP
FINAL DISPOSITION PROCESSED
07/10/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/03/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/03/2018
GPNX
NOTIFICATION PROCESSED BY IB
01/27/2018
PUBO
PUBLISHED FOR OPPOSITION
01/16/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/10/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/10/2018
NPUB
NOTICE OF PUBLICATION
12/27/2017
RFNT
REFUSAL PROCESSED BY IB
12/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/17/2017
RFRR
REFUSAL PROCESSED BY MPU
11/17/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/07/2017
CNRT
NON-FINAL ACTION WRITTEN
11/06/2017
DOCK
ASSIGNED TO EXAMINER
11/03/2017
MAFR
APPLICATION FILING RECEIPT MAILED
11/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/26/2017
Continuous trademark protection
Get notified about every new filing that threatens HENSIFY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.